Trademarks
INREBIC
- Serial number
- 86690908
- Registration number
- 4931750
- Filed
- 2015-07-13
- Registered
- 2016-04-05 · renewed 2026-04-05
- Status
- Registered and renewed (USPTO status code 800, 2026-03-30; as of the dataset)
- Classes
- 005
- Elsewhere
- USPTO TSDR record (current status) ↗
- Source
- TRTDXFAP, file of 2026-04-22
Goods and services
Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune system ]
Owners
| Owner | Role | Entity | Place | Also on furp.org | Source |
|---|---|---|---|---|---|
| Celgene Corporation | Original applicant, Owner at publication, Original registrant | Corporation | Summit, NJ | TRTDXFAP, file of 2026-04-22 | |
| IMPACT BIOMEDICINES, INC. | New owner after registration | Corporation | SUMMIT, NJ | IMPACT BIOMEDICINES, INC. State business registration EXACT high confidence: identical full name and state | TRTDXFAP, file of 2026-04-22 |
Assignment history
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2018-11-29 | Assignment Assigns the entire interest | CELGENE CORPORATION | IMPACT BIOMEDICINES, INC. SUMMIT, NJ | 6543/632 | TRASECO, file of 2026-09-29 |
USPTO bulk data: the Trademark Case Files Dataset (TRCFECO2; the latest release, March 2024, runs through 2023) for marks, owners, classes and goods and services; the Trademark Assignment Dataset (TRASECO) for assignments. Marks filed in the last 20 years, plus older marks still registered. Status here is read from the dataset’s dates and status code; TSDR has the current status. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.